|Bid||8.38 x 3100|
|Ask||8.40 x 4000|
|Day's range||7.75 - 8.39|
|52-week range||0.25 - 18.77|
|Beta (5Y monthly)||4.30|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The most recent examples are the explosive upward moves by shares of Donald Trump's social media-associated stocks, Digital World Acquisition (NASDAQ: DWAC) and Phunware (NASDAQ: PHUN). Last week, Digital World Acquisition's shares rose by as much as 1,500%. Mergers and acquisitions have been the name of the game for biotech investors this year.
Ocugen's share price has skyrocketed roughly seven times more than Novavax's has. Does that make Ocugen the smarter vaccine stock to buy right now? Here are seven reasons why Novavax stock is a no-brainer pick over Ocugen.
What's really interesting about the stock market is there are always new companies trying new things. And sometimes the stocks of these companies come out of nowhere and blow the market averages away.